FAP and non-small cell lung carcinoma: Similarly to α‐SMA+ myCAFs, FAP+ myCAFs are rather ubiquitous in NSCLC, exhibiting variable expression of α‐SMA, although they are most abundant in late stages, LUSC, and solid type LUAD [22] (Fig. 3).